CORDEN PHARMA CHENOVE

Overview

CORDEN PHARMA CHENOVE is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering BISOPROLOL FUMARATE; CHOLINE FENOFIBRATE DRUG SUBSTANCE; FENOFIBRATE; FENOFIBRATE INTERMEDIATE DRUG SUBSTANCE; NEBIVOLOL HYDROCHLORIDE; OXYBUTYNIN HYDROCHLORIDE.

API / Drug Master Files

CORDEN PHARMA CHENOVE holds 7 active (7 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • NEBIVOLOL HYDROCHLORIDEActive2015-12-03
  • CHOLINE FENOFIBRATE DRUG SUBSTANCEActive2007-10-15
  • FENOFIBRATE INTERMEDIATE DRUG SUBSTANCEActive2007-07-24
  • TETRABENAZINEActive2003-07-03
  • BISOPROLOL FUMARATEActive1998-12-22
  • OXYBUTYNIN HYDROCHLORIDEActive1997-01-09
  • FENOFIBRATEActive1996-08-05

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CORDEN PHARMA CHENOVE in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.